Annual report [Section 13 and 15(d), not S-K Item 405]

Nature of Business - Additional Information (Details)

v3.26.1
Nature of Business - Additional Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 25, 2023
Nov. 30, 2025
Oct. 31, 2024
May 31, 2024
Jan. 31, 2023
Jun. 30, 2021
Dec. 31, 2020
Dec. 31, 2025
Dec. 31, 2024
Organization Consolidation And Presentation [Line Items]                  
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs         $ 1,000,000     $ 107,617,495 $ 103,477,668
Accumulated deficit               (142,679,800) (94,420,611)
Cash               139,220,208 56,490,579
Cash, cash equivalents and marketable securities               178,800,000  
Cash and cash equivalents               178,800,000 97,500,000
Marketable securities               39,543,820 $ 41,052,949
ATM Agreement                  
Organization Consolidation And Presentation [Line Items]                  
Accumulated deficit               142,700,000  
Net proceeds from agent (Private Placement)               $ 500,000  
Common Stock                  
Organization Consolidation And Presentation [Line Items]                  
Issuance of common stock, Shares 466,799                
Common stock price to public $ 5.16                
Private Placement | Common Stock | ATM Agreement                  
Organization Consolidation And Presentation [Line Items]                  
Net proceeds from agent (Private Placement)   $ 107,600,000 $ 99,600,000 $ 3,200,000 $ 8,500,000 $ 41,100,000 $ 14,600,000